Recent studies demonstrated that C/EBP-β is a negative regulator of miR-145 via activation of the Akt pathway in breast cancer cells [49], and that EGFR downregulates miR-145 in colon cancer cells [50]. This evidence concerns the gene CEBPB and breast carcinoma.